OUTIN FUTURES CORP.

Form 483 issued August 12, 2022 · Chungju, South Korea

Inspection
Aug 8 – Aug 12, 2022
Investigator
Sonya M. Edmonds
Observations
7
Pages
4
FEI number
3011572099

In short: On August 12, 2022, FDA issued a Form 483 with 7 observations to OUTIN FUTURES CORP. in Chungju, Chungcheongbuk-do (FEI 3011572099) after an inspection that ran Aug 8 – Aug 12, 2022. The investigator was Sonya M. Edmonds. Most observations concern laboratory controls and production; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and production account for 5 of 7 observations.

Laboratory controls3
Production2
Quality system1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Employees are not given training in…

  2. 02

    Accelerated stability studies, combined with basic stability information, used to support tentative expiration dates are not…

  3. 03

    Laboratory controls do not include the establishment of scientifically sound and appropriate standards and test procedures…

  4. 04

    EIPLOYEE(S) SIGNATURE (the Republic of) In-process materials are not tested for and approved or rejected by…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at OUTIN FUTURES CORP.?

FDA listed 7 observations on this Form 483, mostly about laboratory controls, production and quality system. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected OUTIN FUTURES CORP.?

Sonya M. Edmonds is named on this Form 483, for the inspection of Aug 8 – Aug 12, 2022. Each investigator has a profile showing what they cite most.

When was OUTIN FUTURES CORP. inspected by FDA?

The inspection ran Aug 8 – Aug 12, 2022, and the Form 483 is dated August 12, 2022.

How do I get the full Form 483 for OUTIN FUTURES CORP.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free